胰臟癌是香港第五大癌症死亡原因，也是全球第七大癌症死亡原因。2020年，全球約有496000宗胰臟癌新確診個案。胰臟癌是一種高度致命的癌症，全球病死率為94.0%。
適應症：Pancreatic Steatosis、Pancreatic Cyst
收案條件
納入條件
- Age 18 or older
- Patients with at least 1 pancreatic cystic lesion presumed to be IPMN or MCN based on CT, MRI or EUS features, with a cyst size ≥ 5mm; or healthy subjects.
- Patients who are able to provide written informed consent to participate in the study and comply with the study procedures.
排除條件
- Unable to provide written informed consent
- Patients with metallic implants or other contraindications to MRI
- Patients with contraindications for endoscopy due to comorbidities
- Patients with known pancreatic cancer or prior pancreatic resection
- Patients with significant alcohol consumption, defined as alcohol intake of over 20 g daily (140 g weekly) for men and 10 g daily (70 g weekly) for women
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。